BRIEF-Endocyte reports Q3 loss per share $0.21
November 09, 2016 at 16:25 PM EST
* Company updated its financial expectations and now anticipates its cash balance at end of 2016 to be above $135 million
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.